Edmond de Rothschild Holding’s AC Immune ACIU Stock Holding History

Edmond de Rothschild Holding’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$10K	–	677
2023 Q4	$10K	Hold	2,000	–	–	﹤0.01%	659
2023 Q3	$5.7K	Buy	2,000 +1,000	+100%	+$3.04K	﹤0.01%	681
2023 Q2	$2.96K	Hold	1,000	–	–	﹤0.01%	709
2023 Q1	$2.34K	Hold	1,000	–	–	﹤0.01%	717
2022 Q4	$2.04K	Hold	1,000	–	–	﹤0.01%	773
2022 Q3	$3K	Hold	1,000	–	–	﹤0.01%	808
2022 Q2	$4K	Buy	+1,000	New	+$3.42K	﹤0.01%	787
2018 Q4	–	Sell	-1,241	Closed	-$10K	–	672
2018 Q3	$10K	Sell	1,241 -335	-21%	-$3.37K	﹤0.01%	701
2018 Q2	$15K	Hold	1,576	–	–	﹤0.01%	697
2018 Q1	$16K	Hold	1,576	–	–	﹤0.01%	713
2017 Q4	$20K	Buy	+1,576	New	+$18.6K	﹤0.01%	712

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Edmond de Rothschild Holding's ACIU Position: Q1 2024 in Review

Edmond de Rothschild Holding sold out of AC Immune (ACIU) in Q1 2024, closing a stake of 2,000 shares — an estimated $10K sold.

Edmond de Rothschild Holding first reported a position in ACIU in Q4 2017 and held it in 11 quarters. The position peaked at $20K in Q4 2017. 37 funds tracked by Wall St. Rank hold ACIU as of Q1 2024.

Edmond de Rothschild Holding reported no remaining AC Immune position as of Q1 2024 after selling out during the quarter.
Edmond de Rothschild Holding sold 2,000 AC Immune shares in Q1 2024, an estimated $10K.
Edmond de Rothschild Holding first reported a position in AC Immune in Q4 2017 and held it in 11 quarters.
Edmond de Rothschild Holding's AC Immune position peaked at $20K in Q4 2017.
37 funds tracked by Wall St. Rank held AC Immune as of Q1 2024.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2024, filed 8 May 2024.